These observations suggest that orthogonally targeting Mtb’s ability to maintain normal aminoacyl tRNA levels could represent a powerful anti-TB strategy, and we hypothesize that synergy would be particularly potent with a candidate proline tRNA synthetase inhibitor since lysine tRNA levels were less drastically impacted by Pth knockdown than proline tRNA levels. Here, PTH is linked to tuberculosis.